Biotechnology at scale: Europe’s next competitiveness Key findings Biotechnology is increasingly important to Europe’s healthcare, food security, industrial decarbonization and strategic autonomy, generating €75.16 billion in gross value added in 2022. The EU retains major scientific strengths, but struggles to translate research into companies, manufacturing capacity, commercial value and broad societal benefits.